Drug development
and diagnostics

Choose the relevant keywords from the list to search for research groups on those specific areas. As the search is cumulative, choose only a few keywords for a general search and more keywords for more refined search. To see all research groups, click the selection underneath the list.

Clear All
All research groups

Research Groups and R&D Platforms: Basic research, Biomarker, Biomedicine, Breast cancer, Cancer, Colorectal cancer, Data mining, Diagnostics, Drug delivery, Drug target, Genomics, Lung cancer, Melanoma, Molecular Cell Biology, Molecular modelling, Next-generation sequencing, Pathology, Personalized medicine, Receptor, Signaling, Squamous cell carcinoma, Target discovery

Research Group:
Signaling of Receptor Tyrosine Kinases in Cancer and Development

Klaus Elenius
klaele[at]utu.fi

Institute of Biomedicine,
University of Turku

Klaus Elenius

Actionable Receptor Tyrosine Kinase Signaling

Basic research, Biomarker, Biomedicine, Breast cancer, Cancer, Colorectal cancer, Data mining, Diagnostics, Drug delivery, Drug target, Genomics, Lung cancer, Melanoma, Molecular Cell Biology, Molecular modelling, Next-generation sequencing, Pathology, Personalized medicine, Receptor, Signaling, Squamous cell carcinoma, Target discovery

Further information

Pauli Ollikka, Project Coordinator

pauli.ollikka@abo.fi
pauli.ollikka@utu.fi

Drug development and diagnostics is a common research profiling area of the University of Turku and Åbo Akademi University funded by the Academy of Finland. This website is a part of this joint initiative bringing together all information that is related to drug discovery and development or diagnostics from both universities.

Drug developmentand diagnostics

Research Group:Signaling of Receptor Tyrosine Kinases in Cancer and Development

Further information

Drug development
and diagnostics

Research Group:
Signaling of Receptor Tyrosine Kinases in Cancer and Development